A comprehensive understanding of the genomic and molecular framework of gynecologic malignancies is critical in the evolution of potent biomarkers for detection and prevention, molecular profiling, and the development of personalized treatment strategies. Advancements in the field of sequencing technologies have supported researchers and clinicians to harness knowledge pertaining to these...